Tech Company Financing Transactions
Virta Health Funding Round
Virta Health closed a $133 million Series E investment round on 4/20/2021. Investors included Tiger Global Management and private investors.
Transaction Overview
Company Name
Announced On
4/20/2021
Transaction Type
Venture Equity
Amount
$133,000,000
Round
Series E
Investors
Tiger Global Management (Lead Investor)
Proceeds Purpose
The company intends to use the funds for research and product innovation, and increase of demand for diabetes reversal from employers, health plans, and government.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
501 Folsom St.
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Overview
Virta is shifting the conversation from diabetes management to reversal. Here's how we do it. It starts with science. Virta addresses the underlying causes of type 2 diabetes using a highly individualized approach to carbohydrate intake and nutritional ketosis, accounting for each patient's unique biochemistry, medications, and lifestyle.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sami Inkinen
Chief Medical Officer
Robert Ratner
Chief Scientific Officer
Jeff Volek
Founder
Stephen Phinney
Vice President
David Harrison
Vice President
David Hatch
VP - Human Resources
Lucia Guillory
VP - Marketing
Meredith Loring
VP - Operations
Amit Shah
VP - Product Management
Divya Bhat
Browse more venture capital transactions:
Prev: 4/20/2021: SES venture capital transaction
Next: 4/20/2021: Adagio Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs